Appointment of Joint Corporate Brokers

RNS Number : 4672T

Haleon PLC

22 July 2022

 

22 July 2022

Haleon plc

Haleon announces appointment of joint corporate brokers

Haleon plc, a global leader in consumer health, is pleased to announce the appointment of Citigroup Global Markets Limited and UBS as its joint corporate brokers, with immediate effect.

ENDS

About Haleon

Haleon (LSE: HLN) is a global leader in consumer health, with brands trusted by millions of consumers globally. The group employs over 22,000 people across 170 markets, who are united by Haleon's purpose - to deliver better everyday health with humanity. Haleon's product portfolio spans five major categories - Oral Health, Pain Relief, Respiratory Health, Digestive Health and Other, and Vitamins, Minerals and Supplements (VMS). Its long-standing brands - such as Advil, Sensodyne, Panadol, Voltaren, Theraflu, Otrivin, Polident, parodontax and Centrum - are built on trusted science, innovation and deep human understanding.

For more information, please visit www.haleon.com  

Contact Details

Investor Relations		Media Relations
Sonya Ghobrial	[phone]	Nidaa Lone	[phone]
Emma White	[phone]	Ross Whittam	[phone]
Rakesh Patel	[phone]

 

END

 

 

APPPPUCAMUPPUBP